stars 1 stars 2 stars 3

Dizlin Pharmaceuticals AB is a privately held Swedish research-based pharmaceutical development company with focus on diseases of the central nervous system in general and on developing improved treatment for advanced stages of Parkinson’s disease in particular. The company conducts research in collaboration with researchers at the University of Gothenburg and Linköping University in Sweden. The company has developed a new patented method for treatment of advanced stages of Parkinson's disease. Dizlin Pharmaceuticals has two products in late phase development stage. The first - Infudopa IntraV™ – is administered intravenously to minimize risks associated with surgery on patients with Parkinson's disease. The second – Infudopa SubC™ – is administered as a continuous subcutaneous infusion by means of a portable pump (similar to insulin infusion for diabetes).

View Top Employees from Dizlin Pharmaceuticals AB

Dizlin Pharmaceuticals AB Questions

Johan Unger is the Board Member of Dizlin Pharmaceuticals AB.

1 people are employed at Dizlin Pharmaceuticals AB.

Dizlin Pharmaceuticals AB is based in Goeteborg, Vaestra Goetaland.

The NAICS codes for Dizlin Pharmaceuticals AB are [325, 32541, 3254, 32].

The SIC codes for Dizlin Pharmaceuticals AB are [2834, 28, 283].

Top Dizlin Pharmaceuticals AB Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users